PHGE
AMEXBiomX Inc.
Website
News25/Ratings3
News · 26 weeks57-8%
2025-10-262026-04-19
Mix3990d
- SEC Filings21(54%)
- Other12(31%)
- Insider3(8%)
- Leadership2(5%)
- M&A1(3%)
Latest news
25 items- SECBiomX Inc. filed SEC Form 8-K: Other Events, Regulation FD Disclosure, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- PRZorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection SystemsNETANYA, Israel, April 16, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company") today highlighted the successful deployment of its Zorronet subsidiary in collaboration with Israel Railways, focused on protecting wildlife and safeguarding national infrastructure. Over the past year, a large-scale pilot project, with an investment by Israel Railways of approximately NIS 800,000, was completed and declared a success. The project achieved a success rate of 98% at keeping large animals - including wild boar, foxes, and gazelles - off of railway tracks in the sections it was deployed in. These animals would otherwise have wandered onto the tracks, thereby preserving ecolog
- SECAmendment: SEC Form SCHEDULE 13D/A filed by BiomX Inc.SCHEDULE 13D/A - BiomX Inc. (0001739174) (Subject)
- SECBiomX Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- PRBiomX Accelerates Defense Technology Buildout with DFSL AcquisitionNETANYA, Israel, April 13, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company") today announced that it has accelerated the exercise of its previously disclosed exclusive option and entered into a definitive agreement to acquire a controlling interest in DFSL, an Israeli defense engineering company that develops a proprietary LADAR (Laser Radar)–based detection systems in the perimeter security, critical infrastructure and counter-UAS markets. This transaction marks the next step in BiomX's expansion into the defense sector, adding a second, complementary capability to its portfolio. With DFSL's deployed, high-precision LADAR technology, the company introduces real-t
- SECSEC Form S-8 filed by BiomX Inc.S-8 - BiomX Inc. (0001739174) (Filer)
- SECBiomX Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - BiomX Inc. (0001739174) (Filer)
- SECBiomX Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- PRBiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security ApplicationsNETANYA, Israel and REHOVOT, Israel, April 10, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) (the "Company") today announced that it has completed the acquisition of 100% of Zorronet from Water.io (TASE: WATR). This acquisition marks BiomX's entry into the defense, security and rescue sector and establishes a foundation for building a diversified portfolio of defense, rescue, and security capabilities aligned with growing global demand. The acquisition was completed pursuant to a definitive agreement with Water.io. Zorronet is a developer of AI-powered command-and-control software that uses artificial intelligence and machine learning to integrate video analytics, drones, sensors, and I
- SECBiomX Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- PRBiomX Obtains Option to Acquire Control of Israeli Laser-Radar Counter-Drone SystemNETANYA, Israel, March 31, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) today announced that it has entered into an option agreement to acquire control of DFSL, a developer of proprietary LADAR (Laser Radar)–based detection systems for security, defense, and critical infrastructure applications. DFSL's LADAR technology combines laser-based sensing with proprietary AI algorithms to detect and respond to both UAV and ground-based intruders. BiomX intends to exercise the option subject to the closing of the underlying agreement and obtaining shareholder approval as necessary or consideration consisting of a combination of cash, promissory note, shares of common stock and warrants. Separat
- PRBiomX Adds Former Mossad Deputy to Advisory BoardNETANYA, Israel, March 30, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE), today announced the appointment of Dr. Ehud (Udi) Levi to its newly formed Advisory Board. Dr. Levi will support the Company in evaluating and pursuing strategic alternatives and business opportunities, with an emphasis on security and defense, aerial response systems, and counter-UAS (C-UAS) technologies. This will include identifying and assessing potential partnerships, transactions, and new business directions aligned with the Company's expansion into security and defense applications. Dr. Levi brings more than three decades of experience in Israeli intelligence and national security. He served in Unit 8200
- SECBiomX Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- PRBiomX Inc. Received NYSE American Notification Letter Regarding Stockholders' Equity DeficiencyNETANYA, Israel, March 27, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) (the "Company") today announced that on March 25, 2026, the Company received a notice from the staff of NYSE American LLC (the "NYSE American") that the Company was not in compliance with the NYSE American's continued listing standards in Part 10, Section 1003(a)(i), (ii), and (iii) of the NYSE American Company Guide (the "Company Guide"), requiring a company to have stockholders' equity of at least $2.0 million if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years, Section 1003(a)(ii) of the Company Guide requiring a company to have stockholders' equity
- PRBiomX Launches Security Subsidiary in Israel and Will Initially Invest Over $3 million In Its OperationsNETANYA, Israel, March 26, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) today announced the launch of X Security & Defense LTD., a new wholly-owned subsidiary. The company will finance its 2026 operations with over $3 million from internal funds, including for operations and acquisitions related to security, defense and first response. For its initial transaction, BiomX has signed a non-binding LOI with an unrelated third party to secure the exclusive distribution rights in Israel for an advanced aerial firefighting system from a drone components and payload developer. The proposed license would grant X Security & Defense the rights to distribute drone-based fire suppression solutions,
- SECSEC Form DEF 14A filed by BiomX Inc.DEF 14A - BiomX Inc. (0001739174) (Filer)
- SECBiomX Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- PRBiomX CEO Issues Letter to StockholdersCEO Letter to Stockholders highlights the Company's strategic and financial reset designed to strengthen BiomX in the near term and unlock future growth opportunitiesDOVER, Del., March 19, 2026 /PRNewswire/ -- BiomX Inc. (NYSE:PHGE), today released the following letter from its Chief Executive Officer to stockholders. Dear Stockholders,Over the past several weeks, BiomX has taken decisive steps to reshape its leadership, priorities, and financial structure. Leadership has evolved, strategic priorities have been sharpened, and we are taking concrete steps intended to improve the Company's financial and operational structure. These changes have not been easy, but they are necessary to put Biom
- INSIDERSEC Form 4 filed by Yeganeh Reuven4 - BiomX Inc. (0001739174) (Issuer)
- INSIDERDirector Yeganeh Reuven sold $3,350,000 worth of shares (670,000 units at $5.00) and converted options into 670,000 shares (SEC Form 4)4 - BiomX Inc. (0001739174) (Issuer)
- SECBiomX Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - BiomX Inc. (0001739174) (Filer)
- PRBiomX Names Michael Oster as Chief Executive Officer, David Rokach Chief Financial Officer to Support Next Phase of GrowthSeasoned financial leaders join BiomX to support strategic execution and advancement of the companyDOVER, Del. and NESS ZIONA, Israel, March 9, 2026 /PRNewswire/ -- BiomX Inc. (NYSE:PHGE), a clinical-stage company developing natural and engineered phage therapies designed to target and destroy harmful bacteria in chronic diseases, today announced the appointment of Michael Oster as Chief Executive Officer and David Rokach as Chief Financial Officer. Oster brings extensive experience in corporate strategy, mergers and acquisitions, and operational leadership across capital-intensive industries including energy, infrastructure, and industrial sectors. Throughout his career, he has led complex
- SECBiomX Inc. filed SEC Form 8-K: Leadership Update8-K - BiomX Inc. (0001739174) (Filer)
- INSIDERSEC Form 3 filed by new insider Bidas Liat Cohavi3 - BiomX Inc. (0001739174) (Issuer)
- SECBiomX Inc. filed SEC Form 8-K: Leadership Update, Other Events8-K - BiomX Inc. (0001739174) (Filer)